Journal List > J Korean Ophthalmol Soc > v.51(3) > 1008751

J Korean Ophthalmol Soc. 2010 Mar;51(3):340-346. Korean.
Published online March 22, 2010.  https://doi.org/10.3341/jkos.2010.51.3.340
Copyright © 2010 The Korean Ophthalmological Society
Analysis of Postoperative Macular Edema in Cataract Patients with Diabetes using Optical Coherence Tomography
Jun Yong Kim, MD, Min Hye Song, MD and Sung Kun Chung, MD, PhD
Department of Ophthalmology and Visual Science, The Catholic University of Korea College of Medicine, Seoul, Korea.

Address reprint requests to Sung Kun Chung, MD, PhD. Department of Ophthalmology, St. Mary's Hospital, The Catholic University of Korea, #62 Yeouido-dong, Yeongdeungpo-gu, Seoul 150-713, Korea. Tel: 82-2-3779-1848, Fax: 82-2-761-6869, Email: eyedoc@catholic.ac.kr
Received April 21, 2009; Accepted December 22, 2009.

Abstract

Purpose

To evaluate the incidence and progression of macular edema (ME) and associated risk factors in diabetic patients.

Methods

In a prospective study, 66 eyes were assessed by optical coherence tomography (OCT) and best-corrected visual acuity was checked before operation at one and three months after operation. ME was defined as an increase of central macular thickness (CMT) by 30% or more after surgery than before operation, as measured by OCT.

Results

The incidence of ME in diabetic patients was 8.8%. The increment of CMT at three months after cataract surgery was statistically significant in the patients of diabetic duration≥10 years (p=0.049). But insulin treatment, the severity of diabetic retinopathy, diabetic nephropathy and hemoglobin A1C were not significant risk factors for ME.

Conclusions

The OCT might be useful to assess the ME after cataract surgery in diabetic patients. In the patients who had long been suffered from diabetes, the incidence of ME could be higher, so cataract surgery should be carefully considered.

Keywords: Cataract surgery; Diabetes; Macular edema; Optical Coherence Tomography

Figures


Figure 1
Mean central macular thickness of study eyes at 1 and 3 months preoperatively after cataract surgery.
Click for larger image


Figure 2
Representative range of cystoids abnormalities of study eyes with macular edema. (A) Preoperative optical coherence tomography (OCT). (B) Post-operative 1 month OCT. (C) Post-operative 3 months OCT.
Click for larger image

Tables


Table 1
Characteristics of patients with diabetes received cataract operation
Click for larger image


Table 2
Clinical characteristics of patients with postoperative macular edema
Click for larger image


Table 3
Increased central macular thickness after cataract operation
Click for larger image


Table 4
Changes of best corrected visual acuity
Click for larger image

References
1. Dowler JG, Hykin PG, Lightman SL, Hamilton AM. Visual acuity following extracapsular cataract extraction in diabetes: a meta-analysis. Eye 1995;9:313–317.
2. Zaczek A, Olivestedt G, Zetterstrom C. Visual outcome after phacoemulsification and IOL implantation in diabetic patients. Br J Ophthalmol 1999;83:1036–1041.
3. Cunliffe IA, Flanagan DW, George ND, et al. Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br J Ophthalmol 1991;75:9–12.
4. Pollack A, Dotan S, Oliver M. Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol 1991;75:547–551.
5. Henricsson M, Heijl A, Janzon L. Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 1996;80:789–793.
6. Kato S, Fukada Y, Hori S, et al. Influence of phacoemulsification and intraocular lens implantation on the course of diabetic retinopathy. J Cataract Refract Surg 1999;25:788–793.
7. Johnson RN, Howard SH, McDonald R, et al. Fluorescein angiography: basic principles and interpretation. In: Ryan SJ, editor. Retina. revised ed. 2. St. Louis: Mosby; 2001.
chap. 55.
8. Flesner P, Sander B, Henning V, et al. Cataract surgery on diabetic patients: a prospective evaluation of risk factors and complications. Acta Ophthalmol Scand 2002;80:19–24.
9. Hayashi K, Igarashi C, Hirata A, et al. Changes in diabetic macular oedema after phacoemulsification surgery. Eye 2009;23:389–396.
10. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007;114:881–889.
11. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1. Arch Ophthalmol 1985;103:1796–1806.
12. Hee MR, Puliafito CA, Wong C, et al. Quantitative assessmentof macular edema with optical coherence tomography. Arch Ophthalmol 1995;113:1019–1029.
13. Goebel W, Kretzchmar-Gross T. Retinal thickness in diabetic retinopathy: a study using optical coherence tomography (OCT). Retina 2002;22:759–767.
14. Chen CH, Liu YC, Wu PC. The combination of intravitreal bevacizumab and phacoemulsification surgery in patients with cataract and coexisting diabetic macular edema. J Ocul Pharmacol Ther 2009;25:83–89.
15. Cardillo J, Melo LA Jr, Costa RA, et al. Comparison of intravitreal versus posterior sub-Tenon's capsule injection of triamcinolone acetonide for diffuse diabetic macular edema. Ophthalmology 2005;112:1557–1563.
16. Larsson J, Zhu M, Sutter F, Gillies MC. Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone. Am J Ophthalmol 2005;139:802–806.
17. Nelson ML, Martidis A. Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 2003;14:39–43.
18. Ray S, D'Amico DJ. Pseudophakic cystoid macular edema. Semin Ophthalmol 2002;17:167–180.